- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Metro Nashville Public Schools Initiative
Experts discuss how to evaluate and communicate the return on investment for continuous glucose monitoring (CGM) coverage to overcome cost-related barriers, explore strategies other payers could adopt based on the success of Metro Nashville Public Schools' initiative to provide CGM devices without prior authorization, and examine the impact of removing prior authorization requirements on appropriate patient selection and utilization, along with which aspects of this model could be adopted by other employers and the resources needed to implement similar programs.
EP: 1.CGM: Redefining Type 2 Diabetes Management
EP: 2.Key Benefits of CGM Technology
EP: 3.CGM's Impact on Clinical Inertia
EP: 4.CGM vs Traditional Monitoring
EP: 5.Understanding CGM Metrics
EP: 6.Health Care System Integration
EP: 7.CGM Coverage and Access
EP: 8.Implementation Barriers
EP: 9.Overcoming Access Challenges
EP: 10.Adoption Strategies
EP: 11.The Metro Nashville Public Schools Initiative
EP: 12.Health Care Quality Impact
EP: 13.Population Outcomes and Return on Value With CGMs
EP: 14.Long-Term Outcomes Assessment
EP: 15.Closing Perspectives
Video content above is prompted by the following:
- How do you evaluate and communicate the return on investment for CGM coverage to help overcome cost-related barriers?
- Based on the success of Metro Nashville Public Schools' initiative to provide CGM devices without prior authorization, what which strategies could other payers adopt, and what challenges might arise in scaling these efforts?
- Based on the success of removing prior authorization requirements in the Metro Nashville initiative:
- How did this change impact appropriate patient selection and utilization?
- What Which specific aspects of this model could other employers adopt?
- What resources or support would employers need to implement similar programs?
MFN Drug Pricing: Risks to Access, Affordability, and Innovation in Health Care
July 16th 2025Adam Colborn, JD, associate vice president of congressional affairs at AMCP, shares insights on the impact of the Most Favored Nation drug pricing order when it comes to access, affordability, and innovations in US health care.
Read More
Contributor: Maternal Health Outcomes Are a Systemic Signal
July 15th 2025Jayme Ambrose, DNP, RN, CCM, of Adobe Population Health, explores how addressing social determinants of health transforms maternal care delivery, reduces disparities, and improves outcomes for mothers and infants.
Read More
